Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene

BACKGROUND AND AIMS: Butyric acid is an intestinal microbiota-produced short-chain fatty acid, which exerts salutary effects on alleviating nonalcoholic fatty liver disease (NAFLD). However, the underlying mechanism of butyrate on regulating hepatic lipid metabolism is largely unexplored. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ze-Hua, Wang, Zi-Xuan, Zhou, Da, Han, Yamei, Ma, Fengguang, Hu, Zhimin, Xin, Feng-Zhi, Liu, Xiao-Lin, Ren, Tian-Yi, Zhang, Feifei, Xue, Yaqian, Cui, Aoyuan, Liu, Zhengshuai, Bai, Jinyun, Liu, Yuxiao, Cai, Genxiang, Su, Weitong, Dai, Xiaozhen, Shen, Feng, Pan, Qin, Li, Yu, Fan, Jian-Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346675/
https://www.ncbi.nlm.nih.gov/pubmed/33989817
http://dx.doi.org/10.1016/j.jcmgh.2021.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346675/
https://www.ncbi.nlm.nih.gov/pubmed/33989817
http://dx.doi.org/10.1016/j.jcmgh.2021.05.006

Ejemplares similares